Table 1.

Means of measurements in the two basic patients groups at baseline and at endpoint

Variable	Subheading	FES (n = 32)	Non-FESa (n = 101)	All groups (n = 133)
Age at baseline (yr)		23.66 ± 5.04	36.68 ± 10.83	33.55 ± 11.22
Illness duration (yr)		0.31 ± 0.47	13.70 ± 8.51	10.48 ± 9.38
Haloperidol equivalent	Baseline	0.74 ± 2.28	5.83 ± 6.14	4.61 ± 5.88
	Endpoint	1.22 ± 2.39	6.34 ± 6.18	5.11 ± 5.93
PANSS-P	Baseline	15.50 ± 6.31	16.45 ± 5.66	16.22 ± 5.81
	Endpoint	13.06 ± 4.29	14.56 ± 4.67	14.20 ± 4.61
PANSS-Nb	Baseline	17.44 ± 8.53	18.40 ± 7.00	18.17 ± 7.37
	Endpoint	19.59 ± 7.51	20.15 ± 6.47	20.02 ± 6.71
PANSS-G	Baseline	25.94 ± 6.38	26.29 ± 7.25	26.20 ± 7.03
	Endpoint	25.81 ± 6.22	26.27 ± 7.09	26.16 ± 6.87
PANSS-EP	Baseline	7.56 ± 3.31	7.35 ± 3.22	7.40 ± 3.23
	Endpoint	7.38 ± 2.85	7.29 ± 3.07	7.31 ± 3.01
Calgary Depression scale	Baseline	0.44 ± 1.24	1.88 ± 3.74	1.53 ± 3.37
	Endpoint	0.38 ± 1.21	0.71 ± 1.39	0.63 ± 1.35
STAI-S	Baseline	50.03 ± 8.36	49.82 ± 12.29	49.87 ± 11.44
	Endpoint	49.72 ± 7.99	47.84 ± 11.36	48.29 ± 10.65
STAI-T	Baseline	49.97 ± 10.50	50.12 ± 11.78	50.08 ± 11.44
	Endpoint	49.94 ± 9.84	50.27 ± 10.80	50.19 ± 10.55
GAF	Baseline	51.41 ± 11.67	49.37 ± 12.22	49.86 ± 12.08
	Endpoint	52.13 ± 11.93	52.41 ± 11.15	52.34 ± 11.29
UKU	Baseline	5.28 ± 4.15	7.63 ± 5.55	7.07 ± 5.33
	Endpoint	5.44 ± 3.87	6.93 ± 4.25	6.57 ± 4.19
Simpson Angus scale	Baseline	1.03 ± 2.65	0.58 ± 1.24	0.69 ± 1.68
	Endpoint	0.91 ± 3.20	0.51 ± 1.43	0.61 ± 2.00

Values are presented as mean ± standard deviation.

FES, first episode patients with schizophrenia; PANSS, Positive and Negative Symptoms Scale; P, positive subscale; N, negative subscale; G, general psychopathology subscale; EP, excitement component subscale; STAI, State-Trait Anxiety Inventory; S, state; T, trait subscales; GAF, General Assessment of Functioning; UKU, Udvalg for Kliniske Undersøgelser scale.

^aPatients at a latter episode. ^b PANSS-N score predicts remission after 12 months.